KCK Ltd. files 2.7% Schedule 13G/A for Sight Sciences
Sight Sciences, Inc. Schedule 13G/A amendment shows KCK Ltd. and Nael Karim Kassar beneficially own 1,438,094 shares of Common Stock, representing 2.7% of the class based on 54,005,984 shares outstanding as of February 26, 2026.
Rhea-AI Filing Summary
Sight Sciences, Inc. Schedule 13G/A amendment shows KCK Ltd. and Nael Karim Kassar beneficially own 1,438,094 shares of Common Stock, representing 2.7% of the class based on 54,005,984 shares outstanding as of February 26, 2026. The filing reports shared voting and dispositive power over these shares and is signed by the filer and Sight Sciences' CEO.
Positive
- None.
Negative
- None.
Insights
Passive holder reports a sub-5% stake with shared control.
The filing lists 1,438,094 shares held by KCK Ltd./Nael Karim Kassar, equal to 2.7% of the outstanding common stock as of February 26, 2026. This position falls below the 5% reporting threshold that typically indicates passive investment intent under Schedule 13G/A.
Because the filing records shared voting and dispositive power, subsequent changes in voting arrangements or holdings would be the primary items to watch in future amendments.
Shared control implies coordinated ownership, not activist intent.
The cover data shows zero sole voting/dispositive power and 1,438,094 in shared power, which signals a non‑controlling stake. Schedule 13G/A classification generally reflects a passive investor rather than an intent to influence management.
Future filings may disclose whether the holder moves above reporting thresholds or shifts to a Schedule 13D, which would change governance implications.
Key Figures
Key Terms
Schedule 13G/A regulatory
beneficially owned financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does KCK Ltd. hold in Sight Sciences (SGHT)?
Does the Schedule 13G/A filing indicate voting control by KCK Ltd.?
Is this a passive or active disclosure for SGHT?
Who signed the Schedule 13G/A amendment for SGHT?
AI-generated analysis. How Rhea-AI works. Not financial advice.